However, it is unknown at this stage whether the NK-CTL express the fractalkine receptor CX3CR1, which is prominently expressed on CD4+CD28− cytotoxic T cells in MS (Broux et al., 2012). Here, CX3CR1 is linked to myeloid sarcoma.